FLUZONE QIV SH 2025

Sanofi Pasteur Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 21, 2025
Approval ID: d041603b-fa96-433c-a9bc-5393aab4a289
Products: 2 registered
Version: 16

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Fluzone Quadrivalent Southern Hemisphere safely and effectively. See full prescribing information for Fluzone Quadrivalent Southern Hemisphere. Fluzone Quadrivalent (Influenza Vaccine) injectable suspension, for intramuscular use 2025 Formula Initial U.S. Approval: 2013

Quick Stats

Total Products2

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.